@ Bendunstan I agree with your sentiments. In regard non-dilutive funding for the stroke / traumatic brain injury work its almost a "no-brainer" (hehe) that positive GLP and Walter Reed outcomes will attract funds from potentially various entities. For TBI I'd bet a penny to a pound that the US Dept of Defense will provide a grant to further the trials into Phase 2/3. TBI has been identified by the DOD as a major issue for them. The Walter Reed facility is the DOD's medical research centre. Big pharma will also take notice and may well want a seat at the table, in particular for the stroke side of things. The risk/reward scenario here is very compelling for NYR given the low market cap presently
- Forums
- ASX - By Stock
- NYR
- Ann: Brain Injury Program GLP Studies Further Update
NYR
nyrada inc.
Add to My Watchlist
4.26%
!
24.5¢

Ann: Brain Injury Program GLP Studies Further Update, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $50.62M |
Open | High | Low | Value | Volume |
23.5¢ | 26.5¢ | 23.5¢ | $327.7K | 1.340M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38262 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 99900 | 0.235 |
1 | 20047 | 0.230 |
1 | 50000 | 0.225 |
6 | 98773 | 0.220 |
3 | 213005 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 125738 | 2 |
0.250 | 10000 | 1 |
0.255 | 3407 | 1 |
0.260 | 4500 | 1 |
0.265 | 124139 | 2 |
Last trade - 15.32pm 18/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online